National Survey on Dyslipidemic Patients

An observational study of Dyslipidemia, run by AstraZeneca at 1,198 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level. Read more about this study

Who is it for?: Ages 18 years and older
Conditions the study is for: Dyslipidemia
How many people: 3,655 participants
Where: 1,198 sitesFrance
Study dates: Jun 2008to Jan 2009
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Study population: First three consecutive dyslipidemic patients seen by GP

Who may be able to join

Diagnosis of dyslipemia made less than 2 years
Treated by a lipid-lowering drug
Agree to take part in the survey

Who cannot join

Patient included in a clinical trial

Trial locations and contacts

1,198 sites in 1 country.

City, postcode or hospital

300 sites in 1 country

France300 sites

Research Site
Abbaretz
Research Site
Abbeville
Research Site
Ablon-sur-Seine
Research Site
Abrest
Research Site
Agde
Research Site
Agen
Research Site
Ahuy
Research Site
Aignay-le-Duc
Research Site
Aigre
Research Site
Aigues-Mortes
Research Site
Aiguillon
Research Site
Aix-en-Othe
Research Site
Aix-en-Provence
Research Site
Aizenay
Research Site
Ajaccio
Research Site
Alban
Research Site
Albens
Research Site
Albertville
Research Site
Albi
Research Site
Alès
Research Site
Alfortville
Research Site
Alleins
Research Site
Allonnes
Research Site
Ambillou-Château
Research Site
Ambleteuse
Research Site
Amboise
Research Site
Amelie LES Bains Palalda
Research Site
Amiens
Research Site
Andance
Research Site
Andernos-les-Bains
Research Site
Andrézieux-Bouthéon
Research Site
Anduze
Research Site
Angers
Research Site
Anglet
Research Site
Angoulême
Research Site
Aniche
Research Site
Annecy
Research Site
Annoeullin
Research Site
Annonay
Research Site
Annot
Research Site
Antibes
Research Site
Antony
Research Site
Anzin
Research Site
Arcachon
Research Site
Argelès-Gazost
Research Site
Argenteuil
Research Site
Arles
Research Site
Arles
Research Site
Arras
Research Site
Arthez-de-Béarn
Research Site
Artigues-près-Bordeaux
Research Site
Artix
Research Site
Arudy
Research Site
Arzacq-Arraziguet
Research Site
Asnières-sur-Seine
Research Site
Aspremont
Research Site
Athis-Mons
Research Site
Aubagne
Research Site
Aubervilliers
Research Site
Aubière
Research Site
Auby
Research Site
Auch
Research Site
Audierne
Research Site
Audresselles
Research Site
Audun-le-Roman
Research Site
Aulnay-sous-Bois
Research Site
Aumale
Research Site
Auray
Research Site
Aureilhan
Research Site
Aurillac
Research Site
Aussonne
Research Site
Auterive
Research Site
Auvers-sur-Oise
Research Site
Auxerre
Research Site
Avignon
Research Site
Avion
Research Site
Avoine
Research Site
Avon
Research Site
Azay-le-Ferron
Research Site
Bachant
Research Site
Badonviller
Research Site
Bages
Research Site
Bagnères-de-Luchon
Research Site
Bagneux
Research Site
Bagnols-sur-Cèze
Research Site
Baho
Research Site
Bailleul
Research Site
Bain-de-Bretagne
Research Site
Bais
Research Site
Baisieux
Research Site
Balaruc-les-Bains
Research Site
Balma
Research Site
Bannalec
Research Site
Barr
Research Site
Bastia
Research Site
Baud
Research Site
Bayeux
Research Site
Bayonne
Research Site
Beaumont
Research Site
Beaumont-de-Lomagne
Research Site
Beaumont-du-Périgord
Research Site
Beaumont-Hague
Research Site
Beaumont-sur-Lèze
Research Site
Beaune-la-Rolande
Research Site
Beaurains
Research Site
Beauvais
Research Site
Beauvois-en-Cambrésis
Research Site
Beauzelle
Research Site
Bègles
Research Site
Bélâbre
Research Site
Belfort
Research Site
Bellegarde-sur-Valserine
Research Site
Bellême
Research Site
Belvès
Research Site
Benfeld
Research Site
Bénouville
Research Site
Benquet
Research Site
Berck
Research Site
Berguette
Research Site
Bernay
Research Site
Bernin
Research Site
Bersée
Research Site
Béruges
Research Site
Besançon
Research Site
Bessan
Research Site
Bessines
Research Site
Beure
Research Site
Beuvrages
Research Site
Beynes
Research Site
Béziers
Research Site
Bezons
Research Site
Billère
Research Site
Biot
Research Site
Biscarrosse
Research Site
Bischheim
Research Site
Blangy-sur-Bresle
Research Site
Blanzay
Research Site
Blénod-lès-Pont-à-Mousson
Research Site
Bobigny
Research Site
Boën-sur-Lignon
Research Site
Bohars
Research Site
BOIS de Nefles Saint PAUL
Research Site
Bois-Colombes
Research Site
Bois-d'Arcy
Research Site
Bois-en-Ardres
Research Site
Bompas
Research Site
Bondues
Research Site
Bonifacio
Research Site
Bonnelles
Research Site
Bonnières-sur-Seine
Research Site
Boos
Research Site
Bordeaux
Research Site
Bordères-sur-l'Échez
Research Site
Bords
Research Site
Bormes-les-Mimosas
Research Site
Bornel
Research Site
Bosmie-l'Aiguille
Research Site
Bouc-Bel-Air
Research Site
Boucau
Research Site
Bouguenais
Research Site
Boulogne-Billancourt
Research Site
Boulogne-sur-Mer
Research Site
Bourbourg
Research Site
Bourbriac
Research Site
Bourg
Research Site
Bourg-de-Péage
Research Site
Bourg-des-Comptes
Research Site
Bourg-Saint-Andéol
Research Site
Bourges
Research Site
Bousse
Research Site
Boutigny-sur-Essonne
Research Site
Braine
Research Site
Brantôme
Research Site
BRAS Panon
Research Site
Bréhan
Research Site
Brest
Research Site
Bretenoux
Research Site
Breteuil
Research Site
Brétigny-sur-Orge
Research Site
Bretteville-du-Grand-Caux
Research Site
Bretteville-l'Orgueilleuse
Research Site
Breuil-le-Sec
Research Site
Breuillet
Research Site
Brignoles
Research Site
Brionne
Research Site
Brive-la-Gaillarde
Research Site
Broglie
Research Site
Bron
Research Site
Brou-sur-Chantereine
Research Site
Brouckerque
Research Site
Bruay-la-Buissière
Research Site
Bruges
Research Site
Bruyères-sur-Oise
Research Site
Burie
Research Site
Burnhaupt-le-Haut
Research Site
Bussière-Badil
Research Site
Cabanac-et-Villagrains
Research Site
Caen
Research Site
Cagnes-sur-Mer
Research Site
Cagny
Research Site
Cahors
Research Site
Cahuzac-sur-Vère
Research Site
Calais
Research Site
Calcatoggio
Research Site
Caluire-et-Cuire
Research Site
Cambo-les-Bains
Research Site
Cambrai
Research Site
Camiers
Research Site
Camors
Research Site
Campagne-lès-Hesdin
Research Site
Canet
Research Site
Cannes
Research Site
Cany-Barville
Research Site
Capbreton
Research Site
Capdenac-Gare
Research Site
Capendu
Research Site
Cappelle-Brouck
Research Site
Carcassonne
Research Site
Carnoules
Research Site
Carquefou
Research Site
Casteljaloux
Research Site
Castelnau-Magnoac
Research Site
Castelnaudary
Research Site
Castets-en-Dorthe
Research Site
Castillon-en-Couserans
Research Site
Castres
Research Site
Castres-Gironde
Research Site
Cauchy-à-la-Tour
Research Site
Caudry
Research Site
Cauro
Research Site
Caussade
Research Site
Caux
Research Site
Cavaillon
Research Site
Caveirac
Research Site
Cavignac
Research Site
Cazes-Mondenard
Research Site
Ceaucé
Research Site
Cenon
Research Site
Cépet
Research Site
Cernay
Research Site
Chailland
Research Site
Chaingy
Research Site
Chaleins
Research Site
Chalon-sur-Saône
Research Site
Chambéry
Research Site
Champagne-sur-Seine
Research Site
Champagnole
Research Site
Champdeniers-Saint-Denis
Research Site
Champenoux
Research Site
Champigneulles
Research Site
Champigny-sur-Marne
Research Site
Champs-sur-Marne
Research Site
Chantepie
Research Site
Charenton-le-Pont
Research Site
Charleville-Mézières
Research Site
Charmont-sous-Barbuise
Research Site
Charnay-lès-Mâcon
Research Site
Chartres
Research Site
Chartrettes
Research Site
Chassieu
Research Site
Château-Landon
Research Site
Château-sur-Epte
Research Site
Châteauroux
Research Site
Châtel-Censoir
Research Site
Châtellerault
Research Site
Châtenois-les-Forges
Research Site
Châtres-sur-Cher
Research Site
Chatte
Research Site
Chaudon
Research Site
Chauffailles
Research Site
Chaulnes
Research Site
Chaumont
Research Site
Chauny
Research Site
Chauvigny
Research Site
Chavannes-sur-Suran
Research Site
Chelles
Research Site
Chenôve
Research Site
Chessy
Research Site
Chevilly-Larue
Research Site
Chigny-les-Roses
Research Site
Chinon
Research Site
Choisy-le-Roi
Research Site
Cholet
Research Site
Chusclan
Research Site
Ciré-d'Aunis
Research Site
Cires-lès-Mello
Research Site
Clairac
Research Site
Clamart
Research Site
Clermont-Ferrand
Research Site
Clichy
Research Site
Cluny
Research Site
Cognac
Research Site
Colmar
Research Site
Colombiès
Research Site
Combles
Research Site
Combourg
Research Site
Comines
Research Site
Commana
Research Site
Communay
Research Site
Comps

Other trials in France

About this study

Official title: Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice.

The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.

Conditions: Dyslipidemia
Keywords: time to lipid-lowering drug implementation, dyslipidemic patients
Medical subject headings: Dyslipidemias

What is being measured

The primary outcome is the main question the study is designed to answer.

time to lipid-lowering drug implementation (immediately, treatment within a period 0-3 month and > 3 month, according to the cardiovascular risk level, (0 risk factor, 1 risk factor, 2 risk factors, ≥ 3 risk factors, secondary prevention).
Measured: Once

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Jun 2008Jan 2009

First posted19 Jun 2008 (estimated)
Study startJun 2008
Study completionJan 2009

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for DyslipidemiaStudies of the same condition, open and under way.
More trials run by AstraZenecaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Cohort
Time perspective: Cross-sectional
Enrolment: 3,655 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT00701402
Sponsor's protocol ID: NIS-CFR-DUM-2007/9
Acronym: PRYSME
Status last verified: Aug 2009
First submitted: 18 Jun 2008
Last updated: 6 Aug 2009
Results posted: No
Data monitoring committee: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruitingObservational study
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Primary Hypercholesterolemia, Mixed Dyslipidemia
Not yet recruiting
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
Lipid Metabolism Disorders
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruiting
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Cardiovascular Diseases, Hypertension
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease

All Dyslipidemia trials

Study at a glance

From the registry record, last updated by the sponsor on 6 Aug 2009. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice.
ClinicalTrials.gov ID: NCT00701402
Acronym / sponsor ID: PRYSME / NIS-CFR-DUM-2007/9
Conditions: Dyslipidemia
Keywords: time to lipid-lowering drug implementation, dyslipidemic patients
Study type: Observational
Recruitment status: Completed
Enrolment: 3,655 participants (actual)
Lead sponsor: AstraZenecaIndustry (pharma, biotech, devices)
Study start: Jun 2008
Study completion: Jan 2009 (actual)
First posted: 19 Jun 2008 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.

Study design

Observational model: Cohort
Time perspective: Cross-sectional

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult
Study population: First three consecutive dyslipidemic patients seen by GP

Key inclusion criteria (3 listed)

Diagnosis of dyslipemia made less than 2 years
Treated by a lipid-lowering drug
Agree to take part in the survey

Key exclusion criteria (1 listed)

Patient included in a clinical trial

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

time to lipid-lowering drug implementation (immediately, treatment within a period 0-3 month and > 3 month, according to the cardiovascular risk level, (0 risk factor, 1 risk factor, 2 risk factors, ≥ 3 risk factors, secondary prevention).
Time frame: Once

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2009.

Related trials for Dyslipidemia

Active, not recruitingObservational study
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Primary Hypercholesterolemia, Mixed Dyslipidemia
Not yet recruiting
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
Lipid Metabolism Disorders
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruiting
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Cardiovascular Diseases, Hypertension
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Alain Castaigne study director

AstraZeneca

1,198 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Dyslipidemia, run by AstraZeneca at 1,198 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1,198 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

time to lipid-lowering drug implementation (immediately, treatment within a period 0-3 month and > 3 month, according to the cardiovascular risk level, (0 risk factor, 1 risk factor, 2 risk factors, ≥ 3 risk factors, secondary prevention). (time frame: Once). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00701402.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2009.